FIELD: medicine. SUBSTANCE: method involves applying helium-neon laser therapy. ALOK-1 apparatus is used before and after aortocoronary by-pass and 300 ml Trental and Corinfar are intravenously administered. EFFECT: prevented disorders of hemorheological parameters; excluded complications. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CERTIFYING HEMORHEOLOGICAL DISORDERS IN CARRYING OUT SURGICAL TREATMENT OF CARDIAC ISCHEMIA DISEASE | 1997 |
|
RU2155348C2 |
METHOD OF CEREBRAL ISCHEMIC INSULT TREATMENT | 1996 |
|
RU2145895C1 |
METHOD FOR PREDICTING COMPLICATIONS IN CASE OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197173C2 |
METHOD FOR TREATING CARDIAC ISCHEMIA DISEASE | 1996 |
|
RU2145487C1 |
METHOD FOR EXAMINING QUALITY OF EXTRARENAL BLOOD CLEARANCE | 1998 |
|
RU2155074C2 |
METHOD FOR TREATING A PATIENT WITH A LARGE-FOCUS MYOCARDIAL INFARCTION | 1998 |
|
RU2197230C2 |
METHOD FOR TREATING VENTRICULAR EXTRASYSTOLE THE CASES OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197241C2 |
METHOD FOR TREATING CEREBRAL BLOOD CIRCULATION DISTURBANCES | 1996 |
|
RU2144787C1 |
NON-SURGICAL METHOD FOR TREATING BENIGN PROSTATE HYPERPLASIA | 1997 |
|
RU2158619C2 |
METHOD FOR DIAGNOSING RENAL TRAUMAS | 1999 |
|
RU2170055C2 |
Authors
Dates
2000-08-27—Published
1996-10-30—Filed